Rigel Pharmaceuticals, Inc. (RIGL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Rigel Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 2.10x | 16.91x | -10.06x | -4.42x | -25.22x | -19.86x |
| P/B Ratio | 1.97x | 89.93x | -8.81x | -18.99x | 14.87x | 17.36x |
| P/S Ratio | 2.62x | 1.65x | 2.16x | 2.15x | 3.03x | 5.44x |
| Profitability | ||||||
| Gross Margin | 93.3% | 89.6% | 93.9% | 98.5% | 99.3% | 99.2% |
| Operating Margin | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% | -26.7% |
| Net Margin | 124.7% | 9.8% | -21.5% | -48.7% | -12.0% | -27.4% |
| EBITDA Margin | 44.7% | 15.9% | -14.5% | -44.8% | -7.6% | -25.5% |
| Liquidity | ||||||
| Current Ratio | 2.42x | 2.13x | 1.86x | 1.78x | 2.43x | 2.18x |
| Quick Ratio | 2.30x | 2.04x | 1.76x | 1.64x | 2.33x | 2.14x |
| Leverage | ||||||
| Debt/Equity | 0.14x | 18.24x | -2.11x | -3.05x | 1.01x | 1.15x |
YoY = year-over-year change. Source: FMP..